首页>
外国专利>
Method of determining outcome of non small-cell lung cancer according to XRCC3 polymorphism
Method of determining outcome of non small-cell lung cancer according to XRCC3 polymorphism
展开▼
机译:根据XRCC3多态性确定非小细胞肺癌预后的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Method for determining a platinum-based chemotherapeutic regimen for treating Non-Small-Cell Lung cancer (NSCLC) in a patient comprising:a) determining the presence or absence of the XRCC3 MetMet polymorphism in a biological sample from the patient,c) determining a platinum-based chemotherapeutic regimen based on the presence or absence of the XRCC3 MetMet polymorphism in the sample,wherein the presence of said polymorphism is indicative of favourable predisposition of said subject to respond to a chemotherapy treatment comprising the combination gemcitabine/cisplatin.
展开▼